Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$582K Sell
4,712
-59,008
-93% -$6.35M ﹤0.01% 1199
2026
Q1
$6.53M Buy
+63,720
New +$6.49M 0.05% 353
2025
Q4
Sell
-7,289
Closed -$630K 1907
2025
Q3
$630K Buy
+7,289
New +$576K 0.01% 1115
2024
Q3
Sell
-17,543
Closed -$1.33M 1949
2024
Q2
$1.33M Buy
+17,543
New +$1.25M 0.01% 925

Other funds holding NUVL

Michael Gelband's NUVL Position: Q2 2026 in Review

Michael Gelband reduced its Nuvalent (NUVL) stake by 93% in Q2 2026, selling an estimated $6.35M and leaving 4,712 shares worth $582K. The position accounts for ﹤0.01% of the portfolio, ranked #1199.

Michael Gelband first reported a position in NUVL in Q2 2024 and has held it in 4 quarters since. The position peaked at $6.53M in Q1 2026. 287 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Michael Gelband held 4,712 shares of Nuvalent worth $582K as of Q2 2026.
  • Michael Gelband sold 59,008 Nuvalent shares in Q2 2026, an estimated $6.35M.
  • Nuvalent made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1199 holding.
  • Michael Gelband first reported a position in Nuvalent in Q2 2024 and has held it in 4 quarters since.
  • Michael Gelband's Nuvalent position peaked at $6.53M in Q1 2026.
  • 287 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.